In-San Kim, a fellow at the KIST and a core founder of SHIFTBIO INC, recently highlighted the potential of exosomes through an interview. Dr. Kim, along with his disciples, founded SHIFTBIO INC., focusing on the development of a proprietary exosome platform technology.
Please check out the full article by clicking the link below:
https://www.mk.co.kr/news/society/10904543
In-San Kim, a fellow at the KIST and a core founder of SHIFTBIO INC, recently highlighted the potential of exosomes through an interview. Dr. Kim, along with his disciples, founded SHIFTBIO INC., focusing on the development of a proprietary exosome platform technology.
Please check out the full article by clicking the link below:
https://www.mk.co.kr/news/society/10904543